Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder

Urology

Volumn 77, Issue 4, 2011, Pages 867-870

  Ghoneim, Islam A ^a   Miocinovic, Ranko ^a   Stephenson, Andrew J ^a   Garcia, Jorge A ^a   Gong, Michael C ^a   Campbell, Steven C ^a   Hansel, Donna E ^a   Fergany, Amr F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; SUNITINIB; VINBLASTINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MICROPAPILLARY BLADDER CANCER; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; FEMALE; HUMANS; INDOLES; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PYRROLES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79953901362     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.11.043     Document Type: Article

References (15)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin. 2010;60:277-300.
2. Amin MB, Ro JY, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder: histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224-1232. (Pubitemid 24362435)
3. Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol. 1999;161:1798-1802. (Pubitemid 29420734)
4. Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol. 2009;22(suppl 2):S96-S118.
5. Sangoi AR, Beck AH, Amin MB, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010;34:1367-1376.
6. Kamat AM, Dinney CP, Gee JR, et al. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. 2007;110:62-67.
7. Samaratunga H, Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder: a clinicopathological and immunohistochemical study. Histopathology. 2004;45:55-64. (Pubitemid 38969562)
8. Lopez-Beltran A, Montironi R, Blanca A, et al. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol. 2010;41:1159-1164.
9. Heudel P, El Karak F, Ismaili N, et al. Micropapillary bladder cancer: a review of Leon Berard Cancer Center experience. BMC Urol. 2009;9:5.
10. Leissner J, Ghoneim MA, Abol-Enein H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171:139-144. (Pubitemid 37549109)
11. Ramalingam P, Middleton LP, Tamboli P, et al. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol. 2003;7:112-119. (Pubitemid 36523046)
12. Santillan A, Kim YW, Zahurak ML, et al. Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma. Int J Gynecol Cancer. 2007;17:601-606. (Pubitemid 46743993)
13. Smith SC, Baras AS, Lee JK, et al. The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer. Cancer Res. 2010;70:1753-1758.
14. Perepletchikov AM, Parwani AV. Micropapillary urothelial carcinoma: clinico-pathologic review. Pathol Res Pract. 2009;205:807-810.
15. Vieweg J, Gschwend JE, Herr HW, et al. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol. 1999;161:449-454.